Overview
Bipolar disorder is a chronic neuropsychiatric condition characterized by recurrent episodes of mania (or hypomania) and depression, affecting approximately 1-2.4% of the global population. It carries significant morbidity — reduced life expectancy by 10-15 years, high suicide risk (~15-20x general population), and substantial metabolic comorbidity (obesity, type 2 diabetes, cardiovascular disease). The condition shares genetic risk loci, neuroinflammatory mechanisms, and microbiome signatures with schizophrenia and depression, suggesting a spectrum of related gut-brain axis disorders.
What distinguishes bipolar disorder in the metallomics-microbiome framework is the convergence of copper/zinc dysregulation, sex-specific fungal associations, and the largely unexplored microbiome effects of lithium — the oldest and most effective mood stabilizer.
Metallomic Signature
Copper/Zinc Ratio
Bipolar disorder shares the elevated Cu/Zn ratio seen in schizophrenia, though the pattern differs between mood states:
- Manic episodes: Higher copper, increased ceruloplasmin (copper-carrying acute-phase protein), elevated oxidative stress markers
- Depressive episodes: Lower zinc, impaired antioxidant defense (Cu/Zn-SOD activity reduced)
- Euthymia (stable): Cu/Zn ratio may partially normalize but remains above healthy controls
- Lithium effect: Lithium alters trace metal distribution, though the mechanism is poorly characterized
Iron
Iron dysregulation is reported in bipolar disorder, with elevated ferritin during manic episodes suggesting an inflammatory acute-phase response rather than true iron excess.
Microbiome Associations
Bacterial Dysbiosis
The bipolar gut microbiome shows alterations consistent with other neuropsychiatric conditions [1] [2]:
- Depleted: faecalibacterium prausnitzii (anti-inflammatory butyrate producer), bifidobacterium, lactobacillus
- Enriched: enterobacteriaceae, certain Clostridia species
- Functional: Reduced SCFA production, increased LPS biosynthesis, altered tryptophan metabolism
- Mood-state dependent: Microbiome composition shifts between manic and depressive episodes, though longitudinal data are limited
Candida albicans: A Sex-Specific Signal
A striking finding: candida albicans IgG antibodies are significantly elevated in bipolar disorder patients with a history of mania, and this association is sex-specific [3]:
- Women with bipolar disorder show strong association between Candida antibodies and cognitive deficits (especially working memory)
- Men show a different pattern — Candida exposure associates with mania history but not cognitive domains
- This sex specificity suggests interaction between fungal colonization, estrogen (metalloestrogens), and immune responses
- candida albicans biofilms concentrate metals and may contribute to local metal dyshomeostasis in the gut
The Lithium-Microbiome Connection
Lithium remains the gold standard for bipolar disorder treatment, yet its microbiome effects are largely unexplored:
- Lithium alters ion transport (competing with Na+, K+, Mg2+, Ca2+) throughout the body, including the gut epithelium
- Lithium inhibits GSK-3beta, which regulates intestinal stem cell proliferation and gut barrier maintenance
- Lithium's renal toxicity (common side effect) may create a secondary gut-kidney axis disruption
- The narrow therapeutic index of lithium (0.6-1.2 mEq/L) means microbiome-mediated absorption variability could be clinically significant
Gut-Brain Axis in Bipolar Disorder
The bipolar gut-brain axis involves:
- Microbiome dysbiosis → reduced SCFA production → impaired gut barrier
- Barrier dysfunction → LPS translocation → systemic inflammation
- Neuroinflammation → microglial activation, altered neurotransmitter synthesis
- Tryptophan diversion → IDO/TDO activation shunts tryptophan from serotonin toward kynurenine pathway
- Kynurenine metabolites → NMDA receptor modulation → mood instability
Metal dysregulation amplifies this cascade: copper excess catalyzes ROS generation that damages the gut barrier, and zinc depletion impairs the immune regulation that normally prevents excessive neuroinflammation.
Associated Conditions
Bipolar disorder shares microbiome and metallomic features with several conditions in the WikiBiome knowledge graph:
| Condition | Shared Features | Significance |
|---|---|---|
| schizophrenia | Cu/Zn dysregulation, Faecalibacterium depletion, Candida association | Shared genetic risk (MHC locus); spectrum relationship |
| depression | SCFA depletion, tryptophan-kynurenine shift, Bifidobacterium loss | Depressive episodes overlap; shared gut-brain mechanism |
| cardiovascular disease | Copper elevation, systemic inflammation, endothelial dysfunction | 2-3x CVD risk in bipolar; shared inflammatory pathway |
| type 2 diabetes | Insulin resistance, microbiome-mediated metabolic dysfunction | 3x T2D risk; shared SCFA depletion |
Open Questions
- Does lithium directly alter gut microbial composition, and if so, is this part of its therapeutic mechanism?
- Can microbiome-targeted interventions reduce mood episode frequency or severity?
- Is the Candida-mania association causal, and if so, would antifungal treatment improve outcomes?
- Does the Cu/Zn ratio predict treatment response to lithium vs. anticonvulsants?
- Can ketogenic diet interventions (being trialed; [4]) work partly through microbiome-metal axis correction?
Key Studies
- [1] — comprehensive review of gut-brain axis across psychiatric conditions
- [3] — sex-specific Candida associations
- [2] — host-microbiome interactions in neuropsychiatric disease
- [4] — ongoing dietary intervention trial
Cross-References
- schizophrenia — spectrum condition with shared metallomic profile
- depression — depressive pole overlap
- candida albicans — fungal association with mania
- copper — elevated in manic episodes
- zinc — depleted; impaired SOD function
- gut brain axis — bidirectional communication pathway